1-(4-bromo-1-methylcyclohexa-2,4-dien-1-yl)sulfonyl-2-(1H-indazol-6-yl)pyrrolo[2,3-b]pyridine
C21H17BrN4O2S — CID 141257539
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-bromo-1-methylcyclohexa-2,4-dien-1-yl)sulfonyl-2-(1H-indazol-6-yl)pyrrolo[2,3-b]pyridine
1-(4-bromo-1-methylcyclohexa-2,4-dien-1-yl)sulfonyl-2-(1H-indazol-6-yl)pyrrolo[2,3-b]pyridine (PubChem CID 141257539) has the molecular formula C21H17BrN4O2S and a molecular weight of 469.36 g/mol. Its IUPAC name is 1-(4-bromo-1-methylcyclohexa-2,4-dien-1-yl)sulfonyl-2-(1H-indazol-6-yl)pyrrolo[2,3-b]pyridine.
Molecular Properties
| Compound Name | 1-(4-bromo-1-methylcyclohexa-2,4-dien-1-yl)sulfonyl-2-(1H-indazol-6-yl)pyrrolo[2,3-b]pyridine |
|---|---|
| PubChem CID | 141257539 |
| Molecular Formula | C21H17BrN4O2S |
| Molecular Weight | 469.36 g/mol |
| Exact Mass | 468.03 |
| IUPAC Name | 1-(4-bromo-1-methylcyclohexa-2,4-dien-1-yl)sulfonyl-2-(1H-indazol-6-yl)pyrrolo[2,3-b]pyridine |
| SMILES | CC1(S(=O)(=O)n2c(-c3ccc4cn[nH]c4c3)cc3cccnc32)C=CC(Br)=CC1 |
| InChI | InChI=1S/C21H17BrN4O2S/c1-21(8-6-17(22)7-9-21)29(27,28)26-19(12-15-3-2-10-23-20(15)26)14-4-5-16-13-24-25-18(16)11-14/h2-8,10-13H,9H2,1H3,(H,24,25) |
| InChIKey | BYAXYNYUKPDPIN-UHFFFAOYSA-N |
| XLogP | 4.75 |
| TPSA | 80.64 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 469.36 |
| LogP ≤ 5 | 4.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141257539 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.